The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from CNW Group

CHINA HEALTH LABS & DIAGNOSTICS LTD. ANNOUNCES CONFERENCE CALL TO DISCUSS RESULTS OF THE YEAR-END AND FOURTH QUARTER

Thursday, April 07, 2011

CHINA HEALTH LABS & DIAGNOSTICS LTD. ANNOUNCES CONFERENCE CALL TO DISCUSS RESULTS OF THE YEAR-END AND FOURTH QUARTER18:01 EDT Thursday, April 07, 2011TSX-V: CHOOTCQX: CHLBFFinancial Results for the Year Ended December 31, 2010 to be Released on April 11, 2011TORONTO, April 7 /CNW/ - China Health Labs & Diagnostics Ltd. ("China Health" or the "Company") (TSXV: CHO) (OTCQX: CHLBF), is pleased to announce that it will be releasing the results of the year and quarter ended December 31, 2010 on April 11, 2011, and will be hosting an investor conference call on Tuesday, April 12, 2011. The purpose of this conference call will be to provide investors with an update of the year-end and fourth quarter results of the Company.  Representing China Health on the conference call will be:  Mr. Shiping (Wilson) Yao, President and Chief Executive Officer  Mr. Adam Kniec, Chief Financial Officer  Mr. Kim Oishi, Member of the Board of Directors  Mr. Chao Zhang, Vice President, FinanceFollowing the update, a question and answer session will be held.  To participate, the time and call-in instructions are as follows:DATE:   Tuesday, April 12, 2011TIME:   10:00am, Eastern TimeParticipant Dial-In Number(s):    North America Toll-Free Dial-In Number: (888) 231-8191    For Toronto and international callers:  (647) 427-7450Conference ID: 58763699(NOTE: In order to join this conference call, you will be required to provide the Conference ID Number)A Taped Replay will be available from 1:00pm Eastern Time on April 12, 2011 to 11:59pm Eastern Time on April 19, 2011.Taped Replay Toll Free Dial-in Number: 1-800-642-1687Taped Replay Toronto and International Dial-in Number: 416-849-0833Taped Replay Password: 58763699Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. For further information: Kim Oishi, Director Telephone:  (416) 865-3351 Email:  koishi@chinahealthlabs.com